Pirkle JL, Schwartz J, Landis JR, Harlan WR. The relationship between blood lead levels and blood pressure and its
cardiovascular risk implications. Am J Epidemiol.1985;121:246-258.
Kopp SJ, Barron JT, Tow JP. Cardiovascular actions of lead and relationship to hypertension: a
review. Environ Health Perspect.1988;78:91-99.
Burt VL, Whelton P, Roccella EJ.
et al. Prevalence of hypertension in the US adult population: results from
the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension.1995;25:305-313.
Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev.1993;15:352-373.
Nowack R, Wiecek A, Exner B, Gretz N, Ritz E. Chronic lead exposure in rats: effects on blood pressure. Eur J Clin Invest.1993;23:433-443.
Vander AJ. Chronic effects of lead on the renin-angiotensin system. Environ Health Perspect.1988;78:77-83.
Korrick SA, Hunter DJ, Rotnitzky A, Hu H, Speizer FE. Lead and hypertension in a sample of middle-aged women. Am J Public Health.1999;89:330-335.
Cowley Jr AW, Roman RJ. The role of the kidney in hypertension. JAMA.1996;275:1581-1589.
Hu H, Aro A, Payton M.
et al. The relationship of bone and blood lead to hypertension: the Normative
Aging Study. JAMA.1996;275:1171-1176.
Brody DJ, Pirkle JL, Kramer RA.
et al. Blood lead levels in the US population: phase 1 of the Third National
Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA.1994;272:277-283.
Gulson BL, Mahaffey KR, Mizon KJ.
et al. Contribution of tissue lead to blood lead in adult female subjects
based on stable lead isotope methods. J Lab Clin Med.1995;125:703-712.
Gulson BL, Jameson CW, Mahaffey KR.
et al. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med.1997;130:51-62.
Smith DR, Osterloh JD, Flegal AR. Use of endogenous, stable lead isotopes to determine release of lead
from the skeleton. Environ Health Perspect.1996;104:60-66.
Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal
women. Environ Res.1988;47:79-94.
Symanski E, Hertz PI. Blood lead levels in relation to menopause, smoking, and pregnancy
history. Am J Epidemiol.1995;141:1047-1058.
Muldoon SB, Cauley JA, Allen L. Effect of bone mineral density changes on blood lead levels in peri-menopausal
women. Paper presented at: Society for Epidemiologic Research; June 1997;
Nash D, Silbergeld E, Magder L, Stolley P. Menopause, hormone replacement therapy (HRT), and blood lead levels
among adult women from NHANES III, 1988-1994 [abstract]. Am J Epidemiol.1998;147:S93.
Silbergeld E, Nash D. Lead and human health: is this mine exhausted. Progress in Environmental Science.2000;1:53-68.
Pirkle JL, Brody DJ, Gunter EW.
et al. The decline in blood lead levels in the United States: the National
Health and Nutrition Examination Surveys (NHANES). JAMA.1994;272:284-291.
Harlan WR. The relationship of blood lead levels to blood pressure in the US population. Environ Health Perspect.1988;78:9-13.
Harlan WR, Landis JR, Schmouder RL.
et al. Blood lead and blood pressure: relationship in the adolescent and adult
US population. JAMA.1985;253:530-534.
Pocock SJ, Shaper AG, Ashby D.
et al. The relationship between blood lead, blood pressure, stroke, and heart
attacks in middle-aged British men. Environ Health Perspect.1988;78:23-30.
Neri LC, Hewitt D, Orser B. Blood lead and blood pressure: analysis of cross-sectional and longitudinal
data from Canada. Environ Health Perspect.1988;78:123-126.
Elwood PC, Davey-Smith G, Oldham PD, Toothill C. Two Welsh surveys of blood lead and blood pressure. Environ Health Perspect.1988;78:119-121.
Elwood PC, Yarnell JW, Oldham PD.
et al. Blood pressure and blood lead in surveys in Wales. Am J Epidemiol.1988;127:942-945.
Sharp DS, Becker CE, Smith AH. Chronic low-level lead exposure: its role in the pathogenesis of hypertension. Med Toxicol.1987;2:210-232.
Sharp DS, Osterloh J, Becker CE.
et al. Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect.1988;78:131-137.
Sharp DS, Osterloh J, Becker CE.
et al. Elevated blood pressure in treated hypertensives with low-level lead
accumulation. Arch Environ Health.1989;44:18-22.
Moller L, Kristensen TS. Blood lead as a cardiovascular risk factor. Am J Epidemiol.1992;136:1091-1100.
Proctor SP, Rotnitzky A, Sparrow D.
et al. The relationship of blood lead and dietary calcium to blood pressure
in the normative aging study. Int J Epidemiol.1996;25:528-536.
Staessen JA, Roels H, Fagard R. Lead exposure and conventional and ambulatory blood pressure: a prospective
population study. JAMA.1996;275:1563-1570.
Staessen J, Sartor F, Roels H.
et al. The association between blood pressure, calcium and other divalent
cations: a population study. J Hum Hypertens.1991;5:485-494.
Hense HW, Filipiak B, Keil U. The association of blood lead and blood pressure in population surveys. Epidemiology.1993;4:173-179.
Hense HW, Filipiak B, Keil U. Alcohol consumption as a modifier of the relation between blood lead
and blood pressure. Epidemiology.1994;5:120-123.
Grandjean P, Hollnagel H, Hedegaard L.
et al. Blood lead-blood pressure relations: alcohol intake and hemoglobin
as confounders. Am J Epidemiol.1989;129:732-739.
Schwartz J. The relationship between blood lead and blood pressure in the NHANES
II survey. Environ Health Perspect.1988;78:15-22.
Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect.1991;91:71-75.
Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health.1995;50:31-37.
Reckelhoff JH. Gender differences in the regulation of blood pressure. Hypertension.2001;37:1199-1208.
Ezzati T, Massey J, Waksburg J.
et al. Sample Design: Third National Health and Nutrition
Examination Survey. Hyattsville, Md: Dept of Health and Human Services, National Center
for Health Statistics; 1992. Publication PHS 92-1387.
Kim R, Rotnitsky A, Sparrow D.
et al. A longitudinal study of low-level lead exposure and impairment of renal
function: the Normative Aging Study. JAMA.1996;275:1177-1181.
Silbergeld E, Watson L. Exposure to lead during reproduction and menopause. Fundam Appl Toxicol.1995;25:167-168.
Muldoon SB, Cauley JA, Kuller LH.
et al. Lifestyle and sociodemographic factors as determinants of blood lead
levels in elderly women. Am J Epidemiol.1994;139:599-608.
Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens.1998;12:587-592.
Hu FB, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease:
the epidemiologic evidence. Am J Cardiol.2002;90:26F-29F.
Batuman V, Landy E, Maesaka JK, Wedeen RP. Contribution of lead to hypertension with renal impairment. N Engl J Med.1983;309:17-21.
Staessen J. Low-level lead exposure, renal function and blood pressure. Verh K Acad Geneeskd Belg.1995;57:527-574.
Sharp DS, Benowitz NL, Osterloh JD.
et al. Influence of race, tobacco use, and caffeine use on the relation between
blood pressure and blood lead concentration. Am J Epidemiol.1990;131:845-854.
Lindquist O, Bengtsson C, Hansson T, Roos B. Bone mineral content in relation to age and menopause in middle-aged
women: a study of bone density in lumbar vertebrae by dual photon absorptiometry
in a population sample of women. Scand J Clin Lab Invest.1981;41:215-223.
Krolner B, Pors NS. Bone mineral content of the lumbar spine in normal and osteoporotic
women: cross-sectional and longitudinal studies. Clin Sci.1982;62:329-336.
Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med.1978;92:964-970.
Lindsay R, Hart DM, Aitken JM.
et al. Long-term prevention of postmenopausal osteoporosis by estrogen: evidence
for an increased bone mass after delayed onset of estrogen treatment. Lancet.1976;1:1038-1041.
Riggs BL, Melton Ld. Involutional osteoporosis. N Engl J Med.1986;314:1676-1686.
Nordin B. Osteoporosis with particular reference to the menopause. In: Alvioli L, ed. The Osteoporotic Syndrome: Detection,
Prevention, and Treatment. New York, NY: Grune & Stratton; 1983.
Lagerkvist BJ, Soderberg HA, Nordberg GF.
et al. Biological monitoring of arsenic, lead and cadmium in occupationally
and environmentally exposed pregnant women. Scand J Work Environ Health.1993;19 Suppl 1:50-53.
Knight EM, Spurlock BG, Edwards CH.
et al. Biochemical profile of African American women during three trimesters
of pregnancy and at delivery. J Nutr.1994;124:943S-953S.
West WL, Knight EM, Edwards CH.
et al. Maternal low level lead and pregnancy outcomes. J Nutr.1994;124:981S-986S.
Webber CE, Chettle DR, Bowins RJ.
et al. Hormone replacement therapy may reduce the return of endogenous lead
from bone to the circulation. Environ Health Perspect.1995;103:1150-1153.
Grandjean P, Nielsen GD, Jorgensen PJ, Horder M. Reference intervals for trace elements in blood: significance of risk
factors. Scand J Clin Lab Invest.1992;52:321-337.
Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic
toxicity: conceptual paradigms. Environ Health Perspect.1998;106:1-8.
Cake KM, Bowins RJ, Vaillancourt C.
et al. Partition of circulating lead between serum and red cells is different
for internal and external sources of lead. Am J Ind Med.1996;29:440-445.
Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med.2002;162:2443-2449.